G.J. Davenport, Ph.D.
Vice President of Government and Strategic Initiatives
Dr. Davenport brings over 28 years of pharmaceutical product development and government contracting experience as a C--Level Executive with both biotech and life science companies. Greg is a founding partner of Dport Federal Group, LLC, a consulting firm that assist various clients in the life science and pharmaceutical industries seeking to conduct business with the Federal Government.
Dr. Davenport oversees TFF’s academic, government, and industry infectious disease and biodefense collaborations and pursues non-dilutive funding to advance TFF’s technology platform and products to address government and commercial needs.
Prior to joining TFF, Dr. Davenport was Vice President at a Washington, DC government relations firm where he secured federal contracts and non-dilutive funding for various Fortune 100 companies, academic institutions, and non-profit organizations. Previously, Dr. Davenport served as an executive with Tunnell Consulting, where he was instrumental in establishing Tunnell Government Services that currently provides scientific and technical support to several federal agencies including the Biomedical Advanced Research and Development Authority (BARDA) and the National Institute of Health Integrated Research Facility (IRF) at Fort Detrick. He has also held roles as President of the biodefense division of DOR Biopharma, Inc.; Director of Vaccine Technology and new business development at Dynport Vaccine Company, a General Dynamics Information Technology Company; and CEO of Dport and Associates, LLC, a broad-based consulting firm.
Dr. Davenport earned a Bachelor of Science degree from Dillard University in New Orleans, Louisiana and received his Ph.D. in Molecular Biology from Howard University in Washington, D.C.